{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:29Z","timestamp":1792788269373,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020784","name":"Gannan Medical University","doi-asserted-by":"publisher","award":["QD201910"],"award-info":[{"award-number":["QD201910"]}],"id":[{"id":"10.13039\/501100020784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022957","name":"Jiangxi Double Thousand Plan","doi-asserted-by":"crossref","award":["jxsq2019101064"],"award-info":[{"award-number":["jxsq2019101064"]}],"id":[{"id":"10.13039\/100022957","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangxi Natural Science Foundation for Distinguished Young Scholars","award":["20212ACB216001"],"award-info":[{"award-number":["20212ACB216001"]}]},{"name":"Jiangxi Key Research and Development Program","award":["20203BBG73063"],"award-info":[{"award-number":["20203BBG73063"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271260"],"award-info":[{"award-number":["32271260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAS \u201cLight of West China\u201d Program","award":["xbzg-zdsys-202005"],"award-info":[{"award-number":["xbzg-zdsys-202005"]}]},{"name":"the Natural Science Foundation of Jiangxi Province","award":["20224BAB216004"],"award-info":[{"award-number":["20224BAB216004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    There is an urgent need to develop effective antiviral drugs to prevent the viral infection caused by constantly circulating SARS-CoV-2 as well as its variants. The main protease (M\n                    <jats:sup>pro<\/jats:sup>\n                    ) of SARS-CoV-2 is a salient enzyme that plays a vital role in viral replication and serves as a fascinating therapeutic target. PF-07304814 is a covalent inhibitor targeting SARS-CoV-2 M\n                    <jats:sup>pro<\/jats:sup>\n                    with favorable inhibition potency and drug-like properties, thus making it a promising drug candidate for the treatment of COVID-19. We previously solved the structure of PF-07304814 in complex with SARS-CoV-2 M\n                    <jats:sup>pro<\/jats:sup>\n                    . However, the binding modes of PF-07304814 with M\n                    <jats:sup>pro<\/jats:sup>\n                    s from evolving SARS-CoV-2 variants is under-determined. In the current study, we expressed six M\n                    <jats:sup>pro<\/jats:sup>\n                    mutants (G15S, K90R, M49I, S46F, V186F, and Y54C) that have been identified in Omicron variants including the recently emerged XBB.1.16 subvariant and solved the crystal structures of PF-07304814 bound to M\n                    <jats:sup>pro<\/jats:sup>\n                    mutants. Structural analysis provided insight into the key molecular determinants responsible for the interaction between PF-07304814 and these mutant M\n                    <jats:sup>pro<\/jats:sup>\n                    s. Patterns for PF-07304814 to bind with these investigated M\n                    <jats:sup>pro<\/jats:sup>\n                    mutants and the wild-type M\n                    <jats:sup>pro<\/jats:sup>\n                    are generally similar but with some differences as revealed by detailed structural comparison. Structural insights presented in this study will inform the development of novel drugs against SARS-CoV-2 and the possible conformation changes of M\n                    <jats:sup>pro<\/jats:sup>\n                    mutants when bound to an inhibitor.\n                  <\/jats:p>","DOI":"10.1186\/s43556-023-00134-2","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T23:21:43Z","timestamp":1691018503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Crystal structures of main protease (Mpro) mutants of SARS-CoV-2 variants bound to PF-07304814"],"prefix":"10.1186","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1895-3040","authenticated-orcid":false,"given":"Haihai","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"issue":"10223","key":"134_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5.","journal-title":"Lancet"},{"issue":"8","key":"134_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727\u201333. https:\/\/doi.org\/10.1056\/NEJMoa2001017.","journal-title":"N Engl J Med"},{"issue":"4","key":"134_CR3","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","author":"Coronaviridae Study Group of the International Committee on Taxonomy of V","year":"2020","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of V. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536\u201344. https:\/\/doi.org\/10.1038\/s41564-020-0695-z.","journal-title":"Nat Microbiol"},{"issue":"10225","key":"134_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(20)30260-9","volume":"395","author":"JT Wu","year":"2020","unstructured":"Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395(10225):689\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(20)30260-9.","journal-title":"Lancet"},{"key":"134_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","volume":"91","author":"DS Hui","year":"2020","unstructured":"Hui DS, Madani EIA, Ntoumi TA, Kock F, Dar R. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264\u20136. https:\/\/doi.org\/10.1016\/j.ijid.2020.01.009.","journal-title":"Int J Infect Dis"},{"issue":"7830","key":"134_CR6","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-020-2608-y","volume":"586","author":"N van Doremalen","year":"2020","unstructured":"van Doremalen N, Lambe T, Spencer A, Belij-Rammerstorfer S, Purushotham JN, Port JR, et al. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature. 2020;586(7830):578\u201382. https:\/\/doi.org\/10.1038\/s41586-020-2608-y.","journal-title":"Nature"},{"issue":"5","key":"134_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2035389.","journal-title":"N Engl J Med"},{"issue":"27","key":"134_CR8","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2034577.","journal-title":"N Engl J Med"},{"issue":"6","key":"134_CR9","doi-asserted-by":"publisher","first-page":"2096970","DOI":"10.1080\/21645515.2022.2096970","volume":"18","author":"L Jin","year":"2022","unstructured":"Jin L, Li Z, Zhang X, Li J, Zhu F, CoronaVac:. A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2. Hum Vaccin Immunother. 2022;18(6):2096970. https:\/\/doi.org\/10.1080\/21645515.2022.2096970.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"134_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41591-022-02162-x","volume":"29","author":"C Kurhade","year":"2023","unstructured":"Kurhade C, Zou J, Xia H, Liu M, Chang HC, Ren P, et al. Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. Nat Med. 2023;29(2):344\u20137. https:\/\/doi.org\/10.1038\/s41591-022-02162-x.","journal-title":"Nat Med"},{"issue":"5","key":"134_CR11","doi-asserted-by":"publisher","first-page":"e2381","DOI":"10.1002\/rmv.2381","volume":"32","author":"LB Shrestha","year":"2022","unstructured":"Shrestha LB, Foster C, Rawlinson W, Tedla N, Bull RA. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: implications for immune escape and transmission. Rev Med Virol. 2022;32(5):e2381. https:\/\/doi.org\/10.1002\/rmv.2381.","journal-title":"Rev Med Virol"},{"issue":"1","key":"134_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.chom.2022.11.012","volume":"31","author":"P Qu","year":"2023","unstructured":"Qu P, Evans JP, Faraone JN, Zheng YM, Carlin C, Anghelina M, et al. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. Cell Host Microbe. 2023;31(1):9\u201317e3. https:\/\/doi.org\/10.1016\/j.chom.2022.11.012.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"134_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41392-023-01391-x","volume":"8","author":"A Zhu","year":"2023","unstructured":"Zhu A, Wei P, Man M, Liu X, Ji T, Chen J, et al. Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB.1.5, BQ.1, BQ.1.1, BF.7 and BA.2.75.2. Signal Transduct Target Ther. 2023;8(1):125. https:\/\/doi.org\/10.1038\/s41392-023-01391-x.","journal-title":"Signal Transduct Target Ther"},{"key":"134_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2023.04.016","author":"M Zappa","year":"2023","unstructured":"Zappa M, Verdecchia P, Angeli F. Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB.1.16. Eur J Intern Med. 2023. https:\/\/doi.org\/10.1016\/j.ejim.2023.04.016.","journal-title":"Eur J Intern Med"},{"issue":"6","key":"134_CR15","doi-asserted-by":"publisher","first-page":"103579","DOI":"10.1016\/j.drudis.2023.103579","volume":"28","author":"T Kronenberger","year":"2023","unstructured":"Kronenberger T, Laufer SA, Pillaiyar T. COVID-19 therapeutics: small-molecule drug development targeting SARS-CoV-2 main protease. Drug Discov Today. 2023;28(6):103579. https:\/\/doi.org\/10.1016\/j.drudis.2023.103579.","journal-title":"Drug Discov Today"},{"issue":"16","key":"134_CR16","doi-asserted-by":"publisher","first-page":"e2117142119","DOI":"10.1073\/pnas.2117142119","volume":"119","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Zhu Y, Liu X, Jin Z, Duan Y, Zhang Q, et al. Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2. Proc Natl Acad Sci U S A. 2022;119(16):e2117142119. https:\/\/doi.org\/10.1073\/pnas.2117142119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"49","key":"134_CR17","doi-asserted-by":"publisher","first-page":"eadd2191","DOI":"10.1126\/sciadv.add2191","volume":"8","author":"R Yadav","year":"2022","unstructured":"Yadav R, Courouble VV, Dey SK, Harrison J, Timm J, Hopkins JB, et al. Biochemical and structural insights into SARS-CoV-2 polyprotein processing by Mpro. Sci Adv. 2022;8(49):eadd2191. https:\/\/doi.org\/10.1126\/sciadv.add2191.","journal-title":"Sci Adv"},{"issue":"1","key":"134_CR18","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1038\/s41467-022-32854-4","volume":"13","author":"J Lee","year":"2022","unstructured":"Lee J, Kenward C, Worrall LJ, Vuckovic M, Gentile F, Ton AT, et al. X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation. Nat Commun. 2022;13(1):5196. https:\/\/doi.org\/10.1038\/s41467-022-32854-4.","journal-title":"Nat Commun"},{"issue":"4","key":"134_CR19","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1002\/med.21783","volume":"41","author":"M Xiong","year":"2021","unstructured":"Xiong M, Su H, Zhao W, Xie H, Shao Q, Xu Y. What coronavirus 3\u00a0C-like protease tells us: from structure, substrate selectivity, to inhibitor design. Med Res Rev. 2021;41(4):1965\u201398. https:\/\/doi.org\/10.1002\/med.21783.","journal-title":"Med Res Rev"},{"key":"134_CR20","doi-asserted-by":"publisher","unstructured":"Agost-Beltran L, de la Hoz-Rodriguez S, Bou-Iserte L, Rodriguez S, Fernandez-de-la-Pradilla A, Gonzalez FV. Advances in the development of SARS-CoV-2 Mpro inhibitors. Molecules. 2022;27(8). https:\/\/doi.org\/10.3390\/molecules27082523.","DOI":"10.3390\/molecules27082523"},{"issue":"1","key":"134_CR21","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1038\/s41467-021-26239-2","volume":"12","author":"B Boras","year":"2021","unstructured":"Boras B, Jones RM, Anson BJ, Arenson D, Aschenbrenner L, Bakowski MA, et al. Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19. Nat Commun. 2021;12(1):6055. https:\/\/doi.org\/10.1038\/s41467-021-26239-2.","journal-title":"Nat Commun"},{"issue":"21","key":"134_CR22","doi-asserted-by":"publisher","first-page":"12725","DOI":"10.1021\/acs.jmedchem.0c01063","volume":"63","author":"RL Hoffman","year":"2020","unstructured":"Hoffman RL, Kania RS, Brothers MA, Davies JF, Ferre RA, Gajiwala KS, et al. Discovery of Ketone-Based covalent inhibitors of Coronavirus 3CL Proteases for the potential therapeutic treatment of COVID-19. J Med Chem. 2020;63(21):12725\u201347. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01063.","journal-title":"J Med Chem"},{"issue":"16","key":"134_CR23","doi-asserted-by":"publisher","first-page":"167706","DOI":"10.1016\/j.jmb.2022.167706","volume":"434","author":"J Li","year":"2022","unstructured":"Li J, Lin C, Zhou X, Zhong F, Zeng P, McCormick PJ, et al. Structural basis of main proteases of coronavirus bound to drug candidate PF-07304814. J Mol Biol. 2022;434(16):167706. https:\/\/doi.org\/10.1016\/j.jmb.2022.167706.","journal-title":"J Mol Biol"},{"key":"134_CR24","doi-asserted-by":"publisher","unstructured":"Motyan JA, Mahdi M, Hoffka G, Tozser J. Potential resistance of SARS-CoV-2 main protease (Mpro) against protease inhibitors: Lessons learned from HIV-1 protease. Int J Mol Sci. 2022;23(7). https:\/\/doi.org\/10.3390\/ijms23073507.","DOI":"10.3390\/ijms23073507"},{"key":"134_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbrc.2022.09.010","volume":"629","author":"AK Padhi","year":"2022","unstructured":"Padhi AK, Tripathi T. Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: design, identification, and correlation with globally circulating viral genomes. Biochem Biophys Res Commun. 2022;629:54\u201360. https:\/\/doi.org\/10.1016\/j.bbrc.2022.09.010.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"134_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/bip.22108","volume":"99","author":"JS Richardson","year":"2013","unstructured":"Richardson JS, Richardson DC. Studying and polishing the PDB\u2019s macromolecules. Biopolymers. 2013;99(3):170\u201382. https:\/\/doi.org\/10.1002\/bip.22108.","journal-title":"Biopolymers"},{"issue":"Pt 2","key":"134_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1107\/s0108767390010224","volume":"47","author":"TA Jones","year":"1991","unstructured":"Jones TA, Zou JY, Cowan SW, Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991;47(Pt 2):110\u20139. https:\/\/doi.org\/10.1107\/s0108767390010224.","journal-title":"Acta Crystallogr A"},{"issue":"Pt 4","key":"134_CR28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1107\/S0907444911035918","volume":"68","author":"IJ Tickle","year":"2012","unstructured":"Tickle IJ. Statistical quality indicators for electron-density maps. Acta Crystallogr D Biol Crystallogr. 2012;68(Pt 4):454\u201367. https:\/\/doi.org\/10.1107\/S0907444911035918.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"25","key":"134_CR29","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1021\/acs.jpclett.2c01193","volume":"13","author":"A Thakur","year":"2022","unstructured":"Thakur A, Sharma G, Badavath VN, Jayaprakash V, Merz KM Jr, Blum G, et al. Primer for Designing Main protease (M(pro)) inhibitors of SARS-CoV-2. J Phys Chem Lett. 2022;13(25):5776\u201386. https:\/\/doi.org\/10.1021\/acs.jpclett.2c01193.","journal-title":"J Phys Chem Lett"},{"issue":"41","key":"134_CR30","doi-asserted-by":"publisher","first-page":"13686","DOI":"10.1039\/d1sc03628a","volume":"12","author":"HTH Chan","year":"2021","unstructured":"Chan HTH, Moesser MA, Walters RK, Malla TR, Twidale RM, John T, et al. Discovery of SARS-CoV-2\u00a0M(pro) peptide inhibitors from modelling substrate and ligand binding. Chem Sci. 2021;12(41):13686\u2013703. https:\/\/doi.org\/10.1039\/d1sc03628a.","journal-title":"Chem Sci"},{"key":"134_CR31","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1038\/ncomms5202","volume":"5","author":"M Sanches","year":"2014","unstructured":"Sanches M, Duffy NM, Talukdar M, Thevakumaran N, Chiovitti D, Canny MD, et al. Structure and mechanism of action of the hydroxy-aryl-aldehyde class of IRE1 endoribonuclease inhibitors. Nat Commun. 2014;5:4202. https:\/\/doi.org\/10.1038\/ncomms5202.","journal-title":"Nat Commun"},{"key":"134_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307\u201326. https:\/\/doi.org\/10.1016\/S0076-6879(97)76066-X.","journal-title":"Methods Enzymol"},{"issue":"Pt 4","key":"134_CR33","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J Appl Crystallogr. 2007;40(Pt 4):658\u201374. https:\/\/doi.org\/10.1107\/S0021889807021206.","journal-title":"J Appl Crystallogr"},{"issue":"Pt 2","key":"134_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 2):213\u201321. https:\/\/doi.org\/10.1107\/S0907444909052925.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 4","key":"134_CR35","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 4):486\u2013501. https:\/\/doi.org\/10.1107\/S0907444910007493.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 1","key":"134_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen VB, Arendall WB 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 1):12\u201321. https:\/\/doi.org\/10.1107\/S0907444909042073.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"1","key":"134_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/pro.2733","volume":"25","author":"G Bianco","year":"2016","unstructured":"Bianco G, Forli S, Goodsell DS, Olson AJ. Covalent docking using autodock: two-point attractor and flexible side chain methods. Protein Sci. 2016;25(1):295\u2013301. https:\/\/doi.org\/10.1002\/pro.2733.","journal-title":"Protein Sci"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-023-00134-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-023-00134-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-023-00134-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T23:22:47Z","timestamp":1691018567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-023-00134-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["134"],"URL":"https:\/\/doi.org\/10.1186\/s43556-023-00134-2","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"4 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that no conflicts of interest exist.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}